CoChat

High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k “Helper” Proteins

Open access
Gwiazda, Kamila S, Grier, Alexandra E, Sahni, Jaya, Burleigh, Stephen M, Martin, Unja, Yang, Julia G, Popp, Nicholas A, Krutein, Michelle C, Khan, Iram F, Jacoby, Kyle, Jensen, Michael C, Rawlings, David J, Scharenberg, Andrew M · 2016 · Molecular Therapy
Cited by 34

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Many future therapeutic applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 and related RNA-guided nucleases are likely to require their use to promote gene targeting, thus necessitating development of methods that provide for delivery of three components-Cas9, guide RNAs and recombination templates-to primary cells rendered proficient for homology-directed repair. Here, we demonstrate an electroporation/transduction codelivery method that utilizes mRNA to express both Cas9 and mutant adenoviral E4orf6 and E1b55k helper proteins in association with adeno-associated virus (AAV) vectors expressing guide RNAs and recombination templates. By transiently enhancing target cell permissiveness to AAV transduction and gene editing efficiency, this novel approach promotes efficient gene disruption and/or gene targeting at multiple loci in primary human T-cells, illustrating its broad potential for application in translational gene editing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2016.105

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 34

Metadata

Authors
Gwiazda, K. S., Grier, A. E., Sahni, J., Burleigh, S. M., Martin, U., Yang, J. G., Popp, N. A., Krutein, M. C., Khan, I. F., Jacoby, K., Jensen, M. C., Rawlings, D. J., & Scharenberg, A. M.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2016-09
Volume
24
Issue
9
Pages
1570-1580
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2399227976
Cited by
34
References
11
FWCI
3.01
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k “Helper” Proteins. https://app.cochat.ai/papers/10.1038/mt.2016.105
The paper
Gwiazda, K. S., Grier, A. E., Sahni, J., Burleigh, S. M., Martin, U., Yang, J. G., Popp, N. A., Krutein, M. C., Khan, I. F., Jacoby, K., Jensen, M. C., Rawlings, D. J., & Scharenberg, A. M. (2016). High Efficiency CRISPR/Cas9-mediated Gene Editing in Primary Human T-cells Using Mutant Adenoviral E4orf6/E1b55k “Helper” Proteins. Molecular Therapy. https://doi.org/10.1038/mt.2016.105

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.